Welcome to P3 Research

Experience super-fast timeframes in as little as 3 months to FPFV.

As a leader in clinical trials we pride ourselves on delivering accurate, fast and independent clinical research data within a safe and high quality environment. 
For Pharma and Biotech companies planning Phase 2 trials, placement of these with us in New Zealand can play a critical role in saving time and money through the avoidance of IND applications and our rapid start-up with short reliable timelines. 
P3 Research Ltd. is an independent clinical research company, and New Zealand’s leading provider of Phase 2 and 3 clinical trials. Our three clinical research sites are capable of performing studies from small scale Phase 2 trials to large scale, longer term Phase 3 studies.



Your data is confidential and will not be shared with any other organisation.

P3 RESEARCH – Your First Choice For Phase 2 and 3 Clinical Trials
Specialists in Phase 2 trials, including overnight stays
Standardised NZ-wide contract and indemnity documents
One-stop contract/budget review
Smooth, rapid processes for regulatory and centralized ethics reviews 
Fast start up / short timelines - as little as 3 months to FPFV 
Reliable and motivated staff and volunteers 
Reliable recruitment 
15 years experience and over 100 trials completed 
Extensive database of volunteers
EXPERIENCE Super fast timeframes with P3
Reponse to Feasibilities 24 to 48 hours
Ethics submission preparation 5 to 7 days
Ethics approval 4 to 6 weeks
Regulatory approval 4 to 6 weeks
Ethics submission to FPFV 3 to 4 months

We work with large and small CROs and can assist you to identify local trial managers to suit your needs




Copyright © P3 Research Limited 2015.

We work with leading pharmaceutical companies

P3 Research World Class Clinical Trials

New Zealand has become a very desirable location for conducting clinical trials because of the quality of its health care professionals, the smooth and centralised ethics and regulatory processes, and the reliable and timely recruitment that can usually be accomplished. Other advantages include high retention rates of motivated volunteers, high ethical standards on par with Western Europe, USA and Australia, excellent communication systems, facilities located in populated centres with easy access to International Airports, and opposite seasons to the Northern Hemisphere - allowing seasonal research to continue year round.

Our Primary Specialities

• COPD, asthma (including allergen challenges and sputum induction) Type 2 diabetes, vaccine studies, chronic pain

• Conditions of high prevalence generally managed in primary care (e.g. skin conditions, migraine, OA, dyslipidaemia, anticoagulation)

We adhere to the highest standards in clinical trial research

• Three dedicated clinical trial research facilities

• Regular sponsor audits over many years, no major findings

• Experienced in house investigators

• Experienced study coordinators

• Internal SOP system and QA procedures

• GCP-ICH compliant

• Certificated for cold chain storage

• Compliant with cold chain storage

Interested in finding out more?
Contact Dr Richard Stubbs MD, Managing Director
Please correct the following errors: